ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,097Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 910

$703K Total Retail Price of All Prescriptions

Rank: 74 out of 910

654 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 654 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 654 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,294 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 401 377 1 1
LISINOPRIL 320 312 2 2
AMLODIPINE BESYLATE 299 285 3 4
OMEPRAZOLE 288 276 4 5
SIMVASTATIN 277 256 5 3
HYDROCODONE-ACETAMINOPHEN 243 225 S3 6 8
METFORMIN HCL 216 193 7 6
LOVASTATIN 214 210 8 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 201 173 9 44
ATORVASTATIN CALCIUM 199 175 10 14
LOSARTAN POTASSIUM 183 154 11 15
SYNTHROID 154 142 12 54
CRESTOR 154 154 12 26
METOPROLOL TARTRATE 149 138 14 7
ATENOLOL 136 134 15 10
ZOLPIDEM TARTRATE 128 98 16 17
FUROSEMIDE 126 121 17 9
WARFARIN SODIUM 124 121 18 11
POTASSIUM CHLORIDE 118 118 19 18
MELOXICAM 113 102 20 76
LOSARTAN-HYDROCHLOROTHIAZIDE 110 100 21 79
METOPROLOL SUCCINATE 106 101 22 21
TAMSULOSIN HCL 104 101 23 29
PRAVASTATIN SODIUM 99 83 24 16
CITALOPRAM HBR 97 90 25 19
FENOFIBRATE 96 83 26 55
HYDROCHLOROTHIAZIDE 90 85 27 12
GLIMEPIRIDE 87 85 28 56
BENAZEPRIL HCL 85 72 29 89
DOXAZOSIN MESYLATE 83 79 30 62
DILTIAZEM ER 79 79 31 105
CEPHALEXIN 78 69 32 90
TRAMADOL HCL 78 72 32 25
ALENDRONATE SODIUM 76 76 34 22
CARVEDILOL 75 67 35 36
GALANTAMINE HBR 71 71 36 241
GABAPENTIN 70 66 37 13
AVODART 68 68 38 203
ALLOPURINOL 68 63 38 33
CLOPIDOGREL 67 59 40 35
FLUTICASONE PROPIONATE 65 58 41 23
PREDNISONE 65 61 41 43
TRIAMTERENE-HCTZ 61 60 43 39
FINASTERIDE 61 61 43 59
CYMBALTA 60 49 45 58
RANITIDINE HCL 60 52 45 28
VYTORIN 55 55 47 82
LANTUS SOLOSTAR 55 55 47 112
TERAZOSIN HCL 53 53 49 61
PANTOPRAZOLE SODIUM 53 40 49 27
GLIPIZIDE 53 47 49 38
METFORMIN HCL ER 53 41 49 77
DONEPEZIL HCL 53 53 49 32
OXYCODONE-ACETAMINOPHEN 52 30 S2 54 31
AMITRIPTYLINE HCL 50 44 R 55 72
ZETIA 50 50 55 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.